

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday. Shares of Cango Inc (NYSE:CANG) fell sharply in...
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cabaletta Bio has a consensus price target of $19.91.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $1.46 last updated October 28, 2026 at 4:00 AM EDT.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA...